In a new 13F filing with the Securities & Exchange Commission, Bank of America Corp DE disclosed that it acquired a new stake in Nurix Therapeutics, Inc. during the second quarter. The filing became public on September 25, 2026.
The institution acquired 842,089 shares of Nurix stock. The shares were valued at approximately $20.43 million. The filing said the position accounts for about 0.81% of Nurix Therapeutics' ownership.
Investments of this size by major financial institutions are often viewed as a positive signal about a company's future prospects and clinical pipeline. The filing also noted that several other large investors have recently bought and sold shares of the company.